Discovery Grants - American Brain Tumor Association
Forecasted
Discovery Grants from the American Brain Tumor Association support early-career faculty testing high-risk, high-impact research ideas to advance brain tumor diagnosis and treatment.
Browse similar grants
Funder: American Brain Tumor Association
Due Dates (Anticipated): December 2026 (LOI) | March 2027 (Full application)
Funding Amounts: Up to $50,000 in direct costs for one year
Summary: Seed funding for early-career faculty pursuing high-risk, high-impact brain tumor research that could change diagnosis or treatment.
Key Information: Applicants must hold a full-time faculty or institution-confirmed equivalent position and meet the eight-year career window.
Description
The American Brain Tumor Association (ABTA) Discovery Grants support novel, high-risk, high-impact research with the potential to change diagnostic or treatment paradigms for brain tumors. The program provides early-stage investigators with seed funding to test new ideas and generate preliminary data for larger grants. Its goals are to advance understanding and treatment and improve, extend, and ultimately save the lives of people living with brain tumors.
Projects may address any brain tumor type—benign or malignant, primary or metastatic—and pediatric, adult, or both populations. Relevant areas include biomarkers, brain tumor biology, clinical research, diagnosis, drug delivery, etiology, genetics, imaging, molecular/genetic epidemiology, novel therapeutics, and risk assessment. Investigators from sciences outside traditional biological fields are encouraged to apply. Projects without a direct connection to brain tumor research are administratively withdrawn.
